National Bank of Canada
IMUX icon

National Bank of Canada’s Immunic IMUX Stock Holding History

National Bank of Canada’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-25
Closed -$250 – 2984
2024
Q4 		$250 Hold
25
– – ﹤0.01% 2754
2024
Q3 		$412 Hold
25
– – ﹤0.01% 2488
2024
Q2 		$274 Hold
25
– – ﹤0.01% 2591
2024
Q1 		$315 Buy
+25
New +$325 ﹤0.01% 2622

Other funds holding IMUX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

National Bank of Canada's IMUX Position: Q1 2025 in Review

National Bank of Canada sold out of Immunic (IMUX) in Q1 2025, closing a stake of 25 shares — an estimated $250 sold.

National Bank of Canada first reported a position in IMUX in Q1 2024 and held it in 4 quarters. The position peaked at $412 in Q3 2024. 64 funds tracked by Wall St. Rank hold IMUX as of Q1 2025.

  • National Bank of Canada reported no remaining Immunic position as of Q1 2025 after selling out during the quarter.
  • National Bank of Canada sold 25 Immunic shares in Q1 2025, an estimated $250.
  • National Bank of Canada first reported a position in Immunic in Q1 2024 and held it in 4 quarters.
  • National Bank of Canada's Immunic position peaked at $412 in Q3 2024.
  • 64 funds tracked by Wall St. Rank held Immunic as of Q1 2025.

Based on National Bank of Canada's 13F filing for Q1 2025, filed 12 May 2025.